Pfizer : PFE

All Pfizer Articles

1524 Articles

Jon C. Ogg | Dec 3, 2013 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More

These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, December 3, 2013.…

Jon C. Ogg | Nov 19, 2013 at 11:50 AM EST

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

ThinkstockThe market for pharmaceuticals and biotech drugs just keeps growing. The so-called patent cliff may be affecting Big Pharma companies…

Jon C. Ogg | Nov 12, 2013 at 9:00 AM EST

Short Sellers Made Big Changes in High-Yield Dividend Stocks

We have now seen the short interest reports from the October 31 settlement date and have compared them to the…

Paul Ausick | Oct 29, 2013 at 8:00 AM EDT

Pfizer Continues to Shrink

Wikimedia CommonsPfizer Inc. (NYSE: PFE) reported third-quarter 2013 results before markets opened Tuesday morning. The drug maker posted adjusted diluted…

Jon C. Ogg | Oct 28, 2013 at 1:19 PM EDT

Merck Sets Low Earnings Bar for Pfizer

The drug patent cliff for Big Pharma is coming with some continued consequences, and two drug giants with earnings this…

Douglas A. McIntyre | Oct 28, 2013 at 6:46 AM EDT

A New Rise in Global Mergers/Buyouts

courtesy of Verizon WirelessMergers and acquisitions (M&A) sometimes can be an excellent measure of the economy’s financial health. However, since…

Jon C. Ogg | Oct 27, 2013 at 8:38 AM EDT

The 10 Most Important Earnings in the Week Ahead

Jon OggEarnings season is in full swing and this coming week will bring many key earnings reports. This will also…

Jon C. Ogg | Oct 25, 2013 at 8:50 AM EDT

Short Sellers Abandoning Bets Against High-Yield Defensive Dividend Stocks

We have seen the short interest reports for the October 15 settlement date. It turns out that short sellers have…

Paul Ausick | Oct 10, 2013 at 10:20 AM EDT

High-Yield Dividend Stocks Face Rising Short Interest

ThinkstockShort sellers have increased their bets against the stable high-dividend stocks that are in most Americans’ retirement accounts and mutual…

Jon C. Ogg | Oct 9, 2013 at 8:15 AM EDT

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown…

Jon C. Ogg | Oct 2, 2013 at 12:25 PM EDT

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

ThinkstockWhen the markets go through periods of great gains, it is not uncommon to see companies start to take more…

Douglas A. McIntyre | Oct 2, 2013 at 6:30 AM EDT

Big Pharma and 100,000 Jobs at Risk

ThinkstockMerck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big…

Jon C. Ogg | Sep 30, 2013 at 10:35 AM EDT

Five FDA Approvals and Reviews at Risk Under a Government Shutdown

via Wikimedia CommonsIt looks like Congress and the president still cannot figure out how to play well with each other,…

Jon C. Ogg | Sep 25, 2013 at 9:40 AM EDT

Short Sellers Pile On and Attack High-Yield Dividend Stocks

ThinkstockShort sellers have increased their bets against the stable high-dividend stocks that are in most Americans’ retirement accounts and mutual…

Jon C. Ogg | Sep 10, 2013 at 12:20 PM EDT

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Wikimedia CommonsChances are high that you already have heard that the Dow Jones Industrial Average (DJIA) is making a serious change…

1 … 71 72 73 74 75 … 102

Pfizer : PFE

All Pfizer Articles

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

Short Sellers Made Big Changes in High-Yield Dividend Stocks

Pfizer Continues to Shrink

Merck Sets Low Earnings Bar for Pfizer

A New Rise in Global Mergers/Buyouts

The 10 Most Important Earnings in the Week Ahead

Short Sellers Abandoning Bets Against High-Yield Defensive Dividend Stocks

High-Yield Dividend Stocks Face Rising Short Interest

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

Big Pharma and 100,000 Jobs at Risk

Five FDA Approvals and Reviews at Risk Under a Government Shutdown

Short Sellers Pile On and Attack High-Yield Dividend Stocks

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Retirement Has Three Spending Phases. Most Budgets Only Cover the First One.

Ron Paul: Trump’s New Policy Is ‘As Dangerous to Liberty and Prosperity’ as Mamdani’s

Broadcom Vs. Nvidia: The Real Challenger and Champion Story in Chips

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.

Retirement Has Three Spending Phases. Most Budgets Only Cover the First One.

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.

Retirement Has Three Spending Phases. Most Budgets Only Cover the First One.

Pfizer : PFE

All Pfizer Articles

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

Short Sellers Made Big Changes in High-Yield Dividend Stocks

Pfizer Continues to Shrink

Merck Sets Low Earnings Bar for Pfizer

A New Rise in Global Mergers/Buyouts

The 10 Most Important Earnings in the Week Ahead

Short Sellers Abandoning Bets Against High-Yield Defensive Dividend Stocks

High-Yield Dividend Stocks Face Rising Short Interest

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

Big Pharma and 100,000 Jobs at Risk

Five FDA Approvals and Reviews at Risk Under a Government Shutdown

Short Sellers Pile On and Attack High-Yield Dividend Stocks

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Retirement Has Three Spending Phases. Most Budgets Only Cover the First One.

Ron Paul: Trump’s New Policy Is ‘As Dangerous to Liberty and Prosperity’ as Mamdani’s

Broadcom Vs. Nvidia: The Real Challenger and Champion Story in Chips

Featured Reads

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.

Retirement Has Three Spending Phases. Most Budgets Only Cover the First One.